European Pharmacovigilance Congress 2023
Conference overview
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated conference on Pharmacovigilance.
Last year, delegates from more than 50 countries worldwide have joined the two days of virtual event followed by the day in presence in Milan.
Growing year after year, the European Pharmacovigilance Congress gathers professionals at all career levels, including key decision makers (e.g. Directors, VPs and Executives) interested in the always evolving pharmacovigilance world and its new trends, and willing to implement more efficient and effective strategies and tools for their departments.
To further improve the value of the congress, the Scientific Board has been widened with the addition of new prestigious, renowned international PV key opinion leaders.
Their deep knowledge and experience, as well as the involvement of excellent speakers on each topic, will ensure the highest scientific level of the program.
The main pharmacovigilance topics, including sessions on pharmacovigilance strategies and trends, new supporting technologies and sessions dedicated to regulatory scenarios from different countries will be covered.
The european pharmacovigilance congress will be a mixed event!
The first two days, November 27 and 28, will be virtual and will see the participation of worldwide experts and key opinion leaders.
The third day, December 1, will be a face to face meeting in Milan, where you will have the chance to meet colleagues and the speakers of the congress: a great opportunity for the PV community to get together!
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
Published by Sage Journals, visit their website here
Congress Format
Two days of virtual conference + one day of face to face meeting in Milan with:
- Presentations & keynote speeches from World Class Speakers
- Focused Round Tables and Q&A sessions participant involvement
- Significant networking opportunities
- Exhibition area for Emerging Technologies and PV solutions
- Publication by Sage of the congress booklet containing the abstracts of presentations and the insights coming from the Round Tables
The European Pharmacovigilance Congress:
Is more than a traditional conference, it is a great opportunity to learn, to develop your professional skills, to get in touch with international renowned experts and colleagues. Discuss and share the strategies and the main trends in the international pharmacovigilance scenario: be part of the community!
Why attend?
- Learn about the latest PV trends and updates
- Share experiences and solutions at A leading european event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies delegates and Speakers
Who should attend?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
Featured Topics 2023
- Evolving Pharmacovigilance Strategies
- Pharmacovigilance in Drug Development
- Pharmacovigilance in ATMP
- Regulations impacting on the global PV system
- Extra-EU Pharmacovigilance regulatory requirements
- Signal Detection & Risk minimization
- Real World Evidence in Pharmacovigilance
- Risk Communication
- Applying Artificial Intelligence to Pharmacovigilance
- Eduravigilance & CTIS Updates
- Pharmacovigilance Quality System – Inspections & Audits
- Pharmacoepidemilogy
27 November 2023 – VIRTUAL
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Gian Nicola Castiglione, Director Global Pharmacovigilance, EU QPPV | Chiesi
Thierry Hamard, Pharmacovigilance & Regulatory Intelligence | Safety Observer
Marcela Fialova, COO and Co-founder | iVigee
Ilaria Grisoni, Executive Director, Head of EU/International PV & Global Risk Management and EEA QPPV | Jazz Pharmaceuticals
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Klaudija Marijanovic Barac, Sr. Director, EU&UK QPPV deputy, Head Periodic Reports & Risk Management Unit at TEVA
Qun-Ying Yue, Associate Professor, Senior Pharmacovigilance Expert | Uppsala Monitoring Centre
Zeljana Margan Koletic, Croatian PRAC Alternate Member, Head of Department for Pharmacovigilance and Rational Pharmacotherapy | HALMED
Annette Rudolph, Pharmacovigilance scientist | Uppsala Monitoring Centre
Michael Von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars | Biogen International
Thomas Debray, Founder, Smart Data Analysis and Statistics B.V.
Susana Perez-Gutthann, Vice President, Global Head Epidemiology | RTI International
Gianluca Trifirò, Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Jan Petracek, CEO | iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Kendal Harrison, Head of Vigilance Development MHRA
Maria Beatrice Panico, Principal consultant at Scendea
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Ivona Bahnik Bisevac, Director Benefit-Risk Management | PrimeVigilance
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Slot reserved for the sponsor
Maddalena Lino, Safety risk Lead Director Pfizer
Nicholas Moore, Emeritus professor of clinical pharmacology | University of Bordeaux
28 November 2023 – VIRTUAL
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Margherita D’Antuono, EU-UK QPPV | Piramal Critical Care
Fazil Afzal, Senior Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Eriko Ogura, Global Head of Drug Safety | Shionogi & Co.,Ltd.
Niteeka Maroo, Head Pharmacovigilance | Piramal Group-India
Hervé Le Louët, Head of PV policy intelligence strategy | Takeda, CIOMS President
Frederic Bouder, Professor in Risk Management, University of Stavanger, Norway
Anita Blackburn, Global Labeling Lead | Labcorp
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Nuccia Oneto, Patient Oriented Programmes Governance Lead | Novartis Italy
Chairperson PEC
Calin Lungu, DDCS S.A., CEO
Mattia Calissano, Head of Drug Safety and Italy and UK LPPV | Orchard Therapeutics
Jan Petracek, CEO | iVigee
Larissa Mege, Global Safety Officer, Sanofi Rare Diseases, Specialty Care Business Unit
Anne De Groot, CEO/CSO and Director | EpiVax
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Sara Lazzarin, Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Vojtech Kvita, CVO, Co-Founder | NextPV Services
Glyn Belcher, CEO of PV Consultancy Ltd
Amalia Alexe, Policy & Liaison Lead, QPPV PRRC Office | Novartis
Jennifer Stevenson, Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation TrusT
Valentina Mancini, Senior Director Pharmacovigilance QPPV | Shionogi Europe
Romina Fernanda Heredia, PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Lana Arafat, Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Gloria Bustos, Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
1 December 2023 – FACE-TO-FACE IN MILAN
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Lembit Rago, Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Eriko Ogura, Global Head of Drug Safety- Shionogy
Ayman Ayoub, VP Business Unit Area Head Safety Surveillance & Risk Management | Pfizer
Andrew Bate, VP Safety Innovation & Analytics | GSK
Sophia Trantza, Senior pharmacovigilance expert
Anna Ruth van Troostenburg De Bruyn, Senior VP Pharmacovigilance & Epidemiology | Gilead Sciences
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Maria Beatrice Panico, Principal consultant at Scendea
Anne Ruth van Troostenburg De Bruyn, EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Elena Prokofjeva, Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Monica Da Luz Carvalho Soares, Health Regulatory Expert, Pharmacovigilance Adviser|Brazilian Health Surveillance Agency (Anvisa)
Calin Lungu, DDCS S.A., CEO
AIFA representative (invited)
PV inspector | FAGG -AFMPS (tbc)
Tea Babić, Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Hrvoje Maček, VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Laura Boga, Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Lucia Biagiotti, EU & UK QPPV, Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Andrea Pieri, Business Development Director | Pharma D&S
Scientific board 2023
Glyn Belcher
CEO | PV Consultancy Ltd
Mattia Calissano
Head of Drug Safety and Italy and UK LPPV | Orchard Therapeutics
Mircea Ciuca
MD, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Lucia Costanzo
Senior Conference Manager at Pharma Education Center
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV, Shionogi Europe
Jan Petracek
CEO of iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV | ADIENNE Pharma & Biotech, Chairperson for EUPV Congress
Confirmed speakers 2023
Fazil Afzal
Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Amalia Alexe
Policy & Liaison Lead, QPPV PRRC Office | Novartis
Lana Arafat
Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Ayman Ayoub
Vice President, Business Unit Area Head, Safety Surveillance and Risk Management | Pfizer
Tea Babić
Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Klaudija Marijanovic Barac
Sr. Director, EU&UK QPPV deputy, Head Periodic Reports and Risk Management Unit | TEVA
Andrew Bate
VP Safety Innovation & Analytics | GSK
Anita Blackburn
Global Labeling Lead | Labcorp
Lucia Biagiotti
EU & UK QPPV | Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Laura Boga
Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Raj Bhogal
Senior Director, R&D Business Strategy & Operations | Jazz Pharmaceuticals
Frederic Emmanuel Bouder
Professor in Risk Management, University of Stavanger, Norway
Gloria Bustos
Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Azira Čajić
Head of Division for Pharmacovigilance and Materiovigilance| Agency for Medicinal Products and Medical Devices Bosnia & Herzegovina-ALMBIH
Gian Nicola Castiglione
Director Global Pharmacovigilance | Chiesi Farmaceutici
David Chonzi
Global Head of PVE | Instil Bio
Margherita D’Antuono
EU-UK QPPV| Piramal Critical Care
Fabio De Gregorio
Vice President, Head of Drug Safety Europe | Shionogi Europe
Anne De Groot
CEO/CSO and Director | Epivax
Thomas Debray
Founder, Smart Data Analysis and Statistics B.V.
Marcela Fialova
Chief Operating Officer | iVigee
Alberto Gramaccioli
Director, Quality Management and Inspections, World Wide Safety | Pfizer inc.
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Sarah Hall
Managing Director | Mipsol Limited
Thierry Hamard
Director | Safety Observer
Dominique Hamerlijnck
Fellow, Patient Expert | EUPATI (European Patient’s Academy for Therapeutic Innovation)
Kendal Harrison
Head of Vigilance Development | Medicines and Healthcare products Regulatory Agency (MHRA)
Romina Fernanda Heredia
PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Paola Kruger
Expert Patient | EUPATI (European Patient’s Academy for Therapeutic Innovation)
Vojtech Kvita
CVO | NextPV Services s.r.o.
Sara Lazzarin
Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Hervé Le Louët
Head of PV policy intelligence strategy | Takeda, President of CIOMS, Past CEO of the UMC, Past President of ISOP
Maddalena Lino
Neurologist, Safety Risk Lead Director | Pfizer
Calin A. Lungu
DDCS S.A., CEO
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine
Zeljana Margan Koletic
Croatian PRAC Alternate Member, Head of Pharmacovigilance Dept (HALMED)
Niteeka Maroo
Head Pharmacovigilance | Piramal Group-India
Larissa Mege
Global Safety Officer, Sanofi Rare Diseases, Speciality Care Business Unit
Nicholas Moore
Emeritus Professor, specialist in Cardiology and Pharmacology | University of Bordeaux
Charalampos Nakos
EU-QPPV | Drug Safety Solutions
Helen Byomire Ndagije
Product Safety Director | The National Drug Authority in Uganda, President of the ISoP Africa chapter
Eriko Ogura
Global Head of Drug Safety | Shionogy
Nuccia Oneto
Patient Oriented Programs Governance Lead | Novartis Farma S.p.A.
Maria Beatrice Panico
Principal consultant | Scendea
Susana Perez-Gutthann
Vice President, Global Head Epidemiology | RTI International
Andrea Pieri
Business Development Director | Pharma D&S
Elena Prokofyeva
Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Hadir Rostom
Lecturer, MSA university & President of ISoP Egypt Chapter
Annette Rudolph
Pharmacovigilance scientist | Uppsala Monitoring Centre
Jennifer Stevenson
Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation Trust
Sophia Trantza
MSc, MSc PV, Senior pharmacovigilance expert
Gianluca Trifirò
Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Anne Ruth van Troostenburg De Bruyn
EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Monica Da Luz Carvalho Soares
Health Regulatory Expert, Pharmacovigilance Adviser | Brazilian Health Surveillance Agency ANVISA
Michael Von Forstner
Global Head of Clinical Safety and Pharmacovigilance | Biogen
Qun Ying Yue
Associate professor Senior Pharmacovigilance Expert | Uppsala Monitoring Center
Ivona Bahnik Bisevac
Director Benefit-Risk Management | PrimeVigilance
Sponsors & Media Partners EUPV2023
Clinpharma
Sponsor
Clinpharma
Sponsor
Clinpharma was born from the desire to offer our customers, operating in the chemical-pharmaceutical sector , a complete range of consultancy services. Each project represents an opportunity for us to demonstrate a solid set of skills and make use of a vast wealth of resources. Our objective is to provide a complete consultancy service to Pharmaceutical companies relating to pharmacovigilance activities (pre and post-marketing), cosmetovigilance, phytovigilance and Supervision of Medical Devices, Regulatory Affairs, Scientific Service, Market access and preparation of the price and reimbursement dossier . The company provides its consultancy in compliance with current European and national regulations and guidelines.
Visit our website »
iVigee
Sponsor
iVigee
Sponsor
iVigee is a technology company led by PV experts transforming the drug safety industry while empowering organizations to enhance PV standards continuously. Our services and technology teams consist of subject matter experts in pharmacovigilance with extensive experience. Industry peers recognize their accomplishments and executive positions within the EMA, other local NCAs, and global pharmaceutical and biotech organizations.
We understand the ever-evolving landscape of drug safety regulations and the need for swift compliance. This is why our teams strive to stay ahead of the curve, ensuring our technologies are state-of-the-art and fully aligned with global regulatory policies. Having the ability to harness the power of these advanced technologies has allowed us to develop a suite of unparalleled products that streamline workflows while creating efficiencies that allow for real-time decision-making.
Join us on this transformative journey as we continue to revolutionize pharmacovigilance and how it will pave the way for a safer, more agile future in patient safety management.
Visit our website »
MedCommunications
Sponsor
MedCommunications
Sponsor
Med Communications has functioned in the pharmaceutical Medical Affairs and Medical Information Contact Center space since its opening in 1998. Over the last 25 years, the company has grown significantly and has evolved into a leading provider of outsourced communication services.
Med Communications specializes in providing flexible, resourceful services designed to support a range of medical affairs department activities on a global scale. The four main services provided are 24/7 medical information/call center, scientific writing, pharmacovigilance, and promotional review.
Every one of Med Communications’ clients has been in the biotechnology, pharmaceutical, medical device, or healthcare industry. Our specialization in this space allows us to provide the efficiencies and experience to service all manner of customers in a regulatory-compliant manner. Our experience managing several pharmaceutical firms globally offer us the ability to provide insight on best practices for our partners continued success.
Visit our website »
Opis
Sponsor
Opis
Sponsor
Established in 1998 by medical doctors with Pharma Industry expertise, OPIS is a leading global clinical CRO with 25 years of experience across diverse therapeutic areas. We offer comprehensive 360° clinical trial support, from study concept development to full project execution, data handling, analysis, and reporting. Our services cover Phase I-IV, interventional, non-interventional, and medical devices studies on an international scale. Additionally, we excel in managing pre- and post-marketing clinical investigations for medical, diagnostic, nutraceutical, and food supplement studies. OPIS is committed to delivering exceptional full-service solutions for the success of clinical trials and medical research.
Visit our website »
Pharma D&S
Sponsor
Pharma D&S
Sponsor
Pharma D&S is an European Service Provider active in Lifescience field with a panel of more than 180 consultants who provide and support pharmaceutical companies in Pharmacovigilance, Clinical Research, Regulatory Affairs and Quality needs. We are partner whit over 400 companies by managing different areas of the product’s entire lifecycle and our customers can find a range of services and a multidisciplinary activities. We believe in the Relationship and client’s Loyalty, in understanding and sharing their goals, integrating with their staff and processes. We trust People, fostering their growth and promoting their commitment. We believe in Innovation and Creativity, in seeking constantly new approaches, ideas and solutions.
Visit our website »
PHV Latam
Sponsor
PHV Latam
Sponsor
PHV Latam was founded in 2016 in Buenos Aires and since then it has been constantly expanding, setting up subsidiaries in Latin America and the EU.
We are specialists in Pharmacovigilance and offering support to the Pharmaceutical Industry with a clear focus on patient safety.
We are committed to provide Marketing Authorisation Holders with tailored pharmaco, techno and cosmetovigilance services, as well as clinical trials, medical information, regulatory affairs, patient programs, PSP support, according to the clients needs and in strict adherence to legislation.
Visit our website »
PrimeVigilance
Sponsor
PrimeVigilance
Sponsor
PrimeVigilance, an Ergomed company, has grown to become the leading Pharmacovigilance specialist company, delivering global solutions for clinical safety and post-marketing pharmacovigilance and medical information from our operational hubs based in Europe, the USA, and Japan.
Our extensive experience enables us to offer a comprehensive, top-quality, cost-effective, and innovative safety solution. Our flexible approach, tailor-made to work with clients, allows us to deliver the services that meet your clinical and post-marketing needs.
PrimeVigilance provides pharmacovigilance solutions to over 200 clients who distribute their products worldwide. PrimeVigilance manages a global Pharmacovigilance system with a choice of leading drug safety databases stretching to more than 100 countries.
Visit our website »
ProductLife Group
Sponsor
ProductLife Group
Sponsor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.
Since 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, market access, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics.
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
Visit our website »
MedTech Outlook
Media Partner
MedTech Outlook
Media Partner
MedTech Outlook is a superlative podium for suppliers to showcase their products and services and healthcare industry professionals to connect with a global audience of decision-makers. Its unique learn-from-peer approach creates an immense impact in the U.S. market, adding a big difference in this continuously evolving medical tech arena.
Visit our website »
Pharma Tech Outlook
Media Partner
Pharma Tech Outlook
Media Partner
Pharma Tech Outlook is a monthly publication that has been a pioneer in bringing forth real-world solutions, news, product trends, solutions, and many more to subscribers. The unique learn-from-peers approach is creating a difference since the decision-makers are constantly sharing their experience, wisdom and thought leadership with each other. Pharma Tech Outlook has contributors from the most established organizations and institutions who have been presenting their viewpoints using this unique print platform. The magazine has been incorporated by some seasoned industry experts and has been at the forefront of presenting a comprehensive and detailed view of the technology arena. Pharma Tech Outlook aims at contributing to the transformation of innovations into services as well as creating a healthy and productive ecosystem.
Visit our website »
Sage
Media Partner
Sage
Media Partner
Published by SAGE, Therapeutic Advances in Drug Safety (Impact Factor: 4.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the 6th edition of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
Website: https://journals.sagepub.com/home/taw
E-mail: jonathan.collin@sagepub.co.uk
Twitter: @TADrugSafety
Visit our website »
Become a sponsor
The European Pharmacovigilance Congress provides an excellent opportunity to get in touch with PV professionals and decision makers through a powerful virtual exhibition area. To sponsor the event, contact us.
Conference Venue
Step 1
On November 27-28 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 1! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of Hilton Garden Inn Milan North.
Conference overview
The European Pharmacovigilance Congress, organized by Pharma Education Center, is recognized as one of the most important and appreciated conference on Pharmacovigilance.
Last year, delegates from more than 50 countries worldwide have joined the two days of virtual event followed by the day in presence in Milan.
Growing year after year, the European Pharmacovigilance Congress gathers professionals at all career levels, including key decision makers (e.g. Directors, VPs and Executives) interested in the always evolving pharmacovigilance world and its new trends, and willing to implement more efficient and effective strategies and tools for their departments.
To further improve the value of the congress, the Scientific Board has been widened with the addition of new prestigious, renowned international PV key opinion leaders.
Their deep knowledge and experience, as well as the involvement of excellent speakers on each topic, will ensure the highest scientific level of the program.
The main pharmacovigilance topics, including sessions on pharmacovigilance strategies and trends, new supporting technologies and sessions dedicated to regulatory scenarios from different countries will be covered.
The european pharmacovigilance congress will be a mixed event!
The first two days, November 27 and 28, will be virtual and will see the participation of worldwide experts and key opinion leaders.
The third day, December 1, will be a face to face meeting in Milan, where you will have the chance to meet colleagues and the speakers of the congress: a great opportunity for the PV community to get together!
ANNUAL EUPV BOOKLET
The 3rd European Pharmacovigilance Congress: speaker abstracts 2019
The 4th European Pharmacovigilance Congress: speaker abstracts 2020
The 5th European Pharmacovigilance Congress: speaker abstracts 2021
The 6th European Pharmacovigilance Congress: speaker abstracts 2022
Published by Sage Journals, visit their website here
Congress Format
Two days of virtual conference + one day of face to face meeting in Milan with:
- Presentations & keynote speeches from World Class Speakers
- Focused Round Tables and Q&A sessions participant involvement
- Significant networking opportunities
- Exhibition area for Emerging Technologies and PV solutions
- Publication by Sage of the congress booklet containing the abstracts of presentations and the insights coming from the Round Tables
The European Pharmacovigilance Congress:
Is more than a traditional conference, it is a great opportunity to learn, to develop your professional skills, to get in touch with international renowned experts and colleagues. Discuss and share the strategies and the main trends in the international pharmacovigilance scenario: be part of the community!
Why attend?
- Learn about the latest PV trends and updates
- Share experiences and solutions at A leading european event
- Forge new collaborations with key decision makers
- Networking through the virtual platform with Pharma Companies delegates and Speakers
Who should attend?
- Pharma, Biotech and Medical Devices Industries
- Pharmacovigilance Associations
- Regulatory Bodies
- CROs and CMOs
- Clinical Research Sites
- Data Management Companies
- Software Development Companies
- University Faculties
- PV Consultant Societies
Featured Topics 2023
- Evolving Pharmacovigilance Strategies
- Pharmacovigilance in Drug Development
- Pharmacovigilance in ATMP
- Regulations impacting on the global PV system
- Extra-EU Pharmacovigilance regulatory requirements
- Signal Detection & Risk minimization
- Real World Evidence in Pharmacovigilance
- Risk Communication
- Applying Artificial Intelligence to Pharmacovigilance
- Eduravigilance & CTIS Updates
- Pharmacovigilance Quality System – Inspections & Audits
- Pharmacoepidemilogy
27 November 2023 - VIRTUAL
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Gian Nicola Castiglione, Director Global Pharmacovigilance, EU QPPV | Chiesi
Thierry Hamard, Pharmacovigilance & Regulatory Intelligence | Safety Observer
Marcela Fialova, COO and Co-founder | iVigee
Ilaria Grisoni, Executive Director, Head of EU/International PV & Global Risk Management and EEA QPPV | Jazz Pharmaceuticals
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Klaudija Marijanovic Barac, Sr. Director, EU&UK QPPV deputy, Head Periodic Reports & Risk Management Unit at TEVA
Qun-Ying Yue, Associate Professor, Senior Pharmacovigilance Expert | Uppsala Monitoring Centre
Zeljana Margan Koletic, Croatian PRAC Alternate Member, Head of Department for Pharmacovigilance and Rational Pharmacotherapy | HALMED
Annette Rudolph, Pharmacovigilance scientist | Uppsala Monitoring Centre
Michael Von Forstner, Global Head, Patient Safety and Pharmacovigilance Biosimilars | Biogen International
Thomas Debray, Founder, Smart Data Analysis and Statistics B.V.
Susana Perez-Gutthann, Vice President, Global Head Epidemiology | RTI International
Gianluca Trifirò, Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Jan Petracek, CEO | iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Kendal Harrison, Head of Vigilance Development MHRA
Maria Beatrice Panico, Principal consultant at Scendea
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Ivona Bahnik Bisevac, Director Benefit-Risk Management | PrimeVigilance
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Slot reserved for the sponsor
Maddalena Lino, Safety risk Lead Director Pfizer
Nicholas Moore, Emeritus professor of clinical pharmacology | University of Bordeaux
28 November 2023 - VIRTUAL
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Margherita D’Antuono, EU-UK QPPV | Piramal Critical Care
Fazil Afzal, Senior Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Eriko Ogura, Global Head of Drug Safety | Shionogi & Co.,Ltd.
Niteeka Maroo, Head Pharmacovigilance | Piramal Group-India
Hervé Le Louët, Head of PV policy intelligence strategy | Takeda, CIOMS President
Frederic Bouder, Professor in Risk Management, University of Stavanger, Norway
Anita Blackburn, Global Labeling Lead | Labcorp
Giovanni Furlan, Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Nuccia Oneto, Patient Oriented Programmes Governance Lead | Novartis Italy
Chairperson PEC
Calin Lungu, DDCS S.A., CEO
Mattia Calissano, Head of Drug Safety and Italy and UK LPPV | Orchard Therapeutics
Jan Petracek, CEO | iVigee
Larissa Mege, Global Safety Officer, Sanofi Rare Diseases, Specialty Care Business Unit
Anne De Groot, CEO/CSO and Director | EpiVax
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Sara Lazzarin, Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Vojtech Kvita, CVO, Co-Founder | NextPV Services
Glyn Belcher, CEO of PV Consultancy Ltd
Amalia Alexe, Policy & Liaison Lead, QPPV PRRC Office | Novartis
Jennifer Stevenson, Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation TrusT
Valentina Mancini, Senior Director Pharmacovigilance QPPV | Shionogi Europe
Romina Fernanda Heredia, PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Lana Arafat, Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Gloria Bustos, Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
1 December 2023 - FACE-TO-FACE IN MILAN
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV /ADIENNE Pharma & Biotech
Arduino Mangoni, Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine, Adelaide, Australia
Lembit Rago, Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Eriko Ogura, Global Head of Drug Safety- Shionogy
Ayman Ayoub, VP Business Unit Area Head Safety Surveillance & Risk Management | Pfizer
Andrew Bate, VP Safety Innovation & Analytics | GSK
Sophia Trantza, Senior pharmacovigilance expert
Anna Ruth van Troostenburg De Bruyn, Senior VP Pharmacovigilance & Epidemiology | Gilead Sciences
Mircea Ciuca, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Maria Beatrice Panico, Principal consultant at Scendea
Anne Ruth van Troostenburg De Bruyn, EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Elena Prokofjeva, Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Monica Da Luz Carvalho Soares, Health Regulatory Expert, Pharmacovigilance Adviser|Brazilian Health Surveillance Agency (Anvisa)
Calin Lungu, DDCS S.A., CEO
AIFA representative (invited)
PV inspector | FAGG -AFMPS (tbc)
Tea Babić, Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Hrvoje Maček, VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Marco Sardella, Chief Pharmacovigilance Officer & EU QPPV | ADIENNE Pharma & Biotech
Laura Boga, Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Lucia Biagiotti, EU & UK QPPV, Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Andrea Pieri, Business Development Director | Pharma D&S
Scientific board 2023
Glyn Belcher
CEO | PV Consultancy Ltd
Mattia Calissano
Head of Drug Safety and Italy and UK LPPV | Orchard Therapeutics
Mircea Ciuca
MD, Global Therapeutic Area Head in Global Clinical Safety and Pharmacovigilance
Lucia Costanzo
Senior Conference Manager at Pharma Education Center
Giovanni Furlan
Worldwide Safety Site Lead – Thessaloniki (Greece), Safety Risk Lead, Director | Pfizer S.r.l.
Hrvoje Maček
VP, Medical & Scientific Affairs, EU QPPV | PrimeVigilance
Valentina Mancini
Senior Director Pharmacovigilance, QPPV, Shionogi Europe
Jan Petracek
CEO of iVigee, Director of Institute of Pharmacovigilance, ISoP Advisory Board
Marco Sardella
Chief Pharmacovigilance Officer & EU-UK QPPV | ADIENNE Pharma & Biotech, Chairperson for EUPV Congress
Confirmed speakers 2023
Fazil Afzal
Medical Assessor | Medicines and Healthcare products Regulatory Agency (MHRA)
Amalia Alexe
Policy & Liaison Lead, QPPV PRRC Office | Novartis
Lana Arafat
Associate Director, Pharmacovigilance | Hikma Pharmaceuticals
Ayman Ayoub
Vice President, Business Unit Area Head, Safety Surveillance and Risk Management | Pfizer
Tea Babić
Director, Head of global PV audits and inspections | Teva Pharmaceuticals
Klaudija Marijanovic Barac
Sr. Director, EU&UK QPPV deputy, Head Periodic Reports and Risk Management Unit | TEVA
Andrew Bate
VP Safety Innovation & Analytics | GSK
Anita Blackburn
Global Labeling Lead | Labcorp
Lucia Biagiotti
EU & UK QPPV | Quality Assurance, Pharmacovigilance system assessment | Pharma D&S
Laura Boga
Head of Global Pharmacovigilance, EU&UK, QP for Pharmacovigilance | Dompé Farmaceutici S.p.A.
Raj Bhogal
Senior Director, R&D Business Strategy & Operations | Jazz Pharmaceuticals
Frederic Emmanuel Bouder
Professor in Risk Management, University of Stavanger, Norway
Gloria Bustos
Senior Director, Head of Pharmacovigilance EMEA and APAC | Baxter
Azira Čajić
Head of Division for Pharmacovigilance and Materiovigilance| Agency for Medicinal Products and Medical Devices Bosnia & Herzegovina-ALMBIH
Gian Nicola Castiglione
Director Global Pharmacovigilance | Chiesi Farmaceutici
David Chonzi
Global Head of PVE | Instil Bio
Margherita D'Antuono
EU-UK QPPV| Piramal Critical Care
Fabio De Gregorio
Vice President, Head of Drug Safety Europe | Shionogi Europe
Anne De Groot
CEO/CSO and Director | Epivax
Thomas Debray
Founder, Smart Data Analysis and Statistics B.V.
Marcela Fialova
Chief Operating Officer | iVigee
Alberto Gramaccioli
Director, Quality Management and Inspections, World Wide Safety | Pfizer inc.
Ilaria Grisoni
Exec. Dir., Head of EU/International PV & Office of QPPV, EEA QPPV | Jazz Pharmaceuticals
Sarah Hall
Managing Director | Mipsol Limited
Thierry Hamard
Director | Safety Observer
Dominique Hamerlijnck
Fellow, Patient Expert | EUPATI (European Patient’s Academy for Therapeutic Innovation)
Kendal Harrison
Head of Vigilance Development | Medicines and Healthcare products Regulatory Agency (MHRA)
Romina Fernanda Heredia
PV Intelligence Coordinator, Head of Project Managers and Business Development | PhV Latam
Paola Kruger
Expert Patient | EUPATI (European Patient’s Academy for Therapeutic Innovation)
Vojtech Kvita
CVO | NextPV Services s.r.o.
Sara Lazzarin
Global Head of Pharmacovigilance Unit | OPIS s.r.l.
Hervé Le Louët
Head of PV policy intelligence strategy | Takeda, President of CIOMS, Past CEO of the UMC, Past President of ISOP
Maddalena Lino
Neurologist, Safety Risk Lead Director | Pfizer
Calin A. Lungu
DDCS S.A., CEO
Arduino Mangoni
Strategic Professor in Clinical Pharmacology | Flinders University, Senior Consultant in Clinical Pharmacology and General Medicine
Zeljana Margan Koletic
Croatian PRAC Alternate Member, Head of Pharmacovigilance Dept (HALMED)
Niteeka Maroo
Head Pharmacovigilance | Piramal Group-India
Larissa Mege
Global Safety Officer, Sanofi Rare Diseases, Speciality Care Business Unit
Nicholas Moore
Emeritus Professor, specialist in Cardiology and Pharmacology | University of Bordeaux
Charalampos Nakos
EU-QPPV | Drug Safety Solutions
Helen Byomire Ndagije
Product Safety Director | The National Drug Authority in Uganda, President of the ISoP Africa chapter
Eriko Ogura
Global Head of Drug Safety | Shionogy
Nuccia Oneto
Patient Oriented Programs Governance Lead | Novartis Farma S.p.A.
Maria Beatrice Panico
Principal consultant | Scendea
Susana Perez-Gutthann
Vice President, Global Head Epidemiology | RTI International
Andrea Pieri
Business Development Director | Pharma D&S
Elena Prokofyeva
Head of the Drug Safety Team, R&D Department | DG PRE, FAMHP
Lembit Rägo
Secretary-General | Council for International Organizations of Medical Sciences (CIOMS)
Hadir Rostom
Lecturer, MSA university & President of ISoP Egypt Chapter
Annette Rudolph
Pharmacovigilance scientist | Uppsala Monitoring Centre
Jennifer Stevenson
Consultant Pharmacist for Older People, Guy’s and St Thomas’ NHS Foundation Trust
Sophia Trantza
MSc, MSc PV, Senior pharmacovigilance expert
Gianluca Trifirò
Professore Ordinario di Farmacologia – Dipartimento di Diagnostica e Sanità Pubblica | Università di Verona
Anne Ruth van Troostenburg De Bruyn
EU QPPV and VP Pharmacovigilance & Epidemiology | Gilead Sciences
Monica Da Luz Carvalho Soares
Health Regulatory Expert, Pharmacovigilance Adviser | Brazilian Health Surveillance Agency ANVISA
Michael Von Forstner
Global Head of Clinical Safety and Pharmacovigilance | Biogen
Qun Ying Yue
Associate professor Senior Pharmacovigilance Expert | Uppsala Monitoring Center
Ivona Bahnik Bisevac
Director Benefit-Risk Management | PrimeVigilance
Sponsors & Media Partners EUPV2023
Clinpharma
Sponsor
Clinpharma
Sponsor
Clinpharma was born from the desire to offer our customers, operating in the chemical-pharmaceutical sector , a complete range of consultancy services. Each project represents an opportunity for us to demonstrate a solid set of skills and make use of a vast wealth of resources. Our objective is to provide a complete consultancy service to Pharmaceutical companies relating to pharmacovigilance activities (pre and post-marketing), cosmetovigilance, phytovigilance and Supervision of Medical Devices, Regulatory Affairs, Scientific Service, Market access and preparation of the price and reimbursement dossier . The company provides its consultancy in compliance with current European and national regulations and guidelines.
Visit our website »
iVigee
Sponsor
iVigee
Sponsor
iVigee is a technology company led by PV experts transforming the drug safety industry while empowering organizations to enhance PV standards continuously. Our services and technology teams consist of subject matter experts in pharmacovigilance with extensive experience. Industry peers recognize their accomplishments and executive positions within the EMA, other local NCAs, and global pharmaceutical and biotech organizations.
We understand the ever-evolving landscape of drug safety regulations and the need for swift compliance. This is why our teams strive to stay ahead of the curve, ensuring our technologies are state-of-the-art and fully aligned with global regulatory policies. Having the ability to harness the power of these advanced technologies has allowed us to develop a suite of unparalleled products that streamline workflows while creating efficiencies that allow for real-time decision-making.
Join us on this transformative journey as we continue to revolutionize pharmacovigilance and how it will pave the way for a safer, more agile future in patient safety management.
Visit our website »
MedCommunications
Sponsor
MedCommunications
Sponsor
Med Communications has functioned in the pharmaceutical Medical Affairs and Medical Information Contact Center space since its opening in 1998. Over the last 25 years, the company has grown significantly and has evolved into a leading provider of outsourced communication services.
Med Communications specializes in providing flexible, resourceful services designed to support a range of medical affairs department activities on a global scale. The four main services provided are 24/7 medical information/call center, scientific writing, pharmacovigilance, and promotional review.
Every one of Med Communications’ clients has been in the biotechnology, pharmaceutical, medical device, or healthcare industry. Our specialization in this space allows us to provide the efficiencies and experience to service all manner of customers in a regulatory-compliant manner. Our experience managing several pharmaceutical firms globally offer us the ability to provide insight on best practices for our partners continued success.
Visit our website »
Opis
Sponsor
Opis
Sponsor
Established in 1998 by medical doctors with Pharma Industry expertise, OPIS is a leading global clinical CRO with 25 years of experience across diverse therapeutic areas. We offer comprehensive 360° clinical trial support, from study concept development to full project execution, data handling, analysis, and reporting. Our services cover Phase I-IV, interventional, non-interventional, and medical devices studies on an international scale. Additionally, we excel in managing pre- and post-marketing clinical investigations for medical, diagnostic, nutraceutical, and food supplement studies. OPIS is committed to delivering exceptional full-service solutions for the success of clinical trials and medical research.
Visit our website »
Pharma D&S
Sponsor
Pharma D&S
Sponsor
Pharma D&S is an European Service Provider active in Lifescience field with a panel of more than 180 consultants who provide and support pharmaceutical companies in Pharmacovigilance, Clinical Research, Regulatory Affairs and Quality needs. We are partner whit over 400 companies by managing different areas of the product’s entire lifecycle and our customers can find a range of services and a multidisciplinary activities. We believe in the Relationship and client’s Loyalty, in understanding and sharing their goals, integrating with their staff and processes. We trust People, fostering their growth and promoting their commitment. We believe in Innovation and Creativity, in seeking constantly new approaches, ideas and solutions.
Visit our website »
PHV Latam
Sponsor
PHV Latam
Sponsor
PHV Latam was founded in 2016 in Buenos Aires and since then it has been constantly expanding, setting up subsidiaries in Latin America and the EU.
We are specialists in Pharmacovigilance and offering support to the Pharmaceutical Industry with a clear focus on patient safety.
We are committed to provide Marketing Authorisation Holders with tailored pharmaco, techno and cosmetovigilance services, as well as clinical trials, medical information, regulatory affairs, patient programs, PSP support, according to the clients needs and in strict adherence to legislation.
Visit our website »
PrimeVigilance
Sponsor
PrimeVigilance
Sponsor
PrimeVigilance, an Ergomed company, has grown to become the leading Pharmacovigilance specialist company, delivering global solutions for clinical safety and post-marketing pharmacovigilance and medical information from our operational hubs based in Europe, the USA, and Japan.
Our extensive experience enables us to offer a comprehensive, top-quality, cost-effective, and innovative safety solution. Our flexible approach, tailor-made to work with clients, allows us to deliver the services that meet your clinical and post-marketing needs.
PrimeVigilance provides pharmacovigilance solutions to over 200 clients who distribute their products worldwide. PrimeVigilance manages a global Pharmacovigilance system with a choice of leading drug safety databases stretching to more than 100 countries.
Visit our website »
ProductLife Group
Sponsor
ProductLife Group
Sponsor
ProductLife Group’s mission is to improve human health by delivering regulatory compliance services for the safe and effective use of medical solutions.
Since 30 years, PLG supports clients through the entire product life cycle, combining local expertise with global reach spanning more than 150 countries. It provides consulting and outsourcing services in the areas of regulatory affairs, quality and compliance, market access, vigilances and medical information, covering both established products and innovative therapeutics & diagnostics.
With a goal of continuously improving the value delivered to people and customers, PLG is committed to long-term partnership, innovation, flexibility, and cost efficiency.
Visit our website »
MedTech Outlook
Media Partner
MedTech Outlook
Media Partner
MedTech Outlook is a superlative podium for suppliers to showcase their products and services and healthcare industry professionals to connect with a global audience of decision-makers. Its unique learn-from-peer approach creates an immense impact in the U.S. market, adding a big difference in this continuously evolving medical tech arena.
Visit our website »
Pharma Tech Outlook
Media Partner
Pharma Tech Outlook
Media Partner
Pharma Tech Outlook is a monthly publication that has been a pioneer in bringing forth real-world solutions, news, product trends, solutions, and many more to subscribers. The unique learn-from-peers approach is creating a difference since the decision-makers are constantly sharing their experience, wisdom and thought leadership with each other. Pharma Tech Outlook has contributors from the most established organizations and institutions who have been presenting their viewpoints using this unique print platform. The magazine has been incorporated by some seasoned industry experts and has been at the forefront of presenting a comprehensive and detailed view of the technology arena. Pharma Tech Outlook aims at contributing to the transformation of innovations into services as well as creating a healthy and productive ecosystem.
Visit our website »
Sage
Media Partner
Sage
Media Partner
Published by SAGE, Therapeutic Advances in Drug Safety (Impact Factor: 4.4) is an international peer-reviewed Open Access journal, delivering the highest quality original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies pertaining to the safe use of drugs in patients. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in drug safety, providing an online forum for rapid dissemination of recent research and perspectives in this area.
As the official Media Partner of the 6th edition of the European Pharmacovigilance Congress, Therapeutic Advances in Drug Safety will be publishing an online abstract supplement which will be free to access online.
For more information:
Website: https://journals.sagepub.com/home/taw
E-mail: jonathan.collin@sagepub.co.uk
Twitter: @TADrugSafety
Visit our website »
Become a sponsor
The European Pharmacovigilance Congress provides an excellent opportunity to get in touch with PV professionals and decision makers through a powerful virtual exhibition area. To sponsor the event, contact us.
Conference Venue
Step 1
On November 27-28 the event will be VIRTUAL to grant you the possibility of joining the conference even from your office or home, wherever you may be. We have organized a true virtual location, a space where you will be able to:
- Follow the live streaming of the congress, listen to experts and opinion makers and be informed about latest trends and technological breakthroughs in drug safety
- Visit the VIRTUAL EXHIBITION AREA and all the stands of our sponsors
- Join Q&A times and round tables to discuss the current hot topics in the field
- Chat with our sponsors and learn about new technologies and services to ease your daily work and increase the performance
Step 2
Let’s finally meet face to face in Milan on December 1! A great chance to meet in person the EUPV experts and colleagues. A great chance to meet in person the EUPV experts and colleagues. The conference will be hosted in the wonderful spaces of Hilton Garden Inn Milan North.
Sign up for the conference
Face to Face (01/12/23) |
650€ |
Virtual (27-28/11/23) |
725€ |
Virtual + Face to Face (27-28/11/23 e 01/12/23) |
985€ |
* Hospitals, Universities and freelancers get a 40% discount on published prices (discounts cannot be combined).